Pulmonary Hypertension and Lung Transplantation

Sophie Kruszona; Khalil Aburahma; Nunzio Davide de Manna; Dmitry Bobylev; Arjang Ruhparwar; Christian Kuehn; Jawad Salman; Fabio Ius

doi:10.1055/a-2590-2620

Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, Table of Contents

Zentralbl Chir 2025; 150(03): 273-285
DOI: 10.1055/a-2590-2620

Thoracic Surgery

Review

Pulmonary Hypertension and Lung Transplantation

Pulmonale Hypertension und Lungentransplantation

Sophie Kruszona

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Khalil Aburahma

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Nunzio Davide de Manna

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Dmitry Bobylev

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Arjang Ruhparwar

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Christian Kuehn

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Jawad Salman

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

,

Fabio Ius

¹Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany (Ringgold ID: RIN9177)

› Author Affiliations

Abstract

Purpose

Pulmonary artery hypertension (PAH), a subtype of pulmonary hypertension, is a rare end-stage lung disease. Bilateral lung and combined heart and lung transplantation have long been considered as a gold standard therapy for PAH.

Methods

This manuscript reviewed the most up-to-date literature on lung transplantation for PAH, focusing particularly on risk stratification, donor allocation, bridging to transplantation (BTT), and intra- and postoperative management in both adult and pediatric patients.

Results

The last two decades have witnessed an important shift in the transplant indications and strategy for PAH. Newly introduced antihypertensive drugs have postponed the time of transplantation in eligible patients, thus reserving transplantation for severely ill high-risk patients on triple antihypertensive therapy. Furthermore, the widespread peritransplant use of veno-arterial extracorporeal membrane oxygenation (ECMO) enables cardiac remodeling after bilateral lung transplantation.

Conclusion

The change in transplant strategy from combined heart and lung transplantation to bilateral lung transplantation renders more organs available for transplantation in an era of organ shortage. ECMO-bridging is a life-saving tool in selected PAH patients although associated with higher complications. Better organ allocation in PAH patients at high risk of decompensation may reduce the need for ECMO-bridging and may further improve outcomes.

Zusammenfassung

Hintergrund

Die pulmonal arterielle Hypertonie (PAH) ist als Untergruppe der pulmonalen Hypertonie eine seltene terminale Lungenerkrankung. Die bilaterale Lungentransplantation und kombinierte Herz-Lungen-Transplantation stellten langzeitig den Goldstandard der Therapie dar.

Methoden

Dieses Review fasst die aktuelle Literatur zur Lungentransplantation bei PAH-Patienten zusammen, fokussiert auf Risikostratifizierungen, Allokation der Spenderorgane, Möglichkeiten der Überbrückung zur Transplantation – die sog. Bridge-to-Transplant-Verfahren (BTT) – sowie das intra- und postoperative Management bei adulten und pädiatrischen Patienten.

Ergebnisse

Basierend auf der Einführung neuer Therapieoptionen bei PAH-Patienten konnte der Zeitpunkt der Transplantation innerhalb der letzten Jahrzehnte verzögert werden. Neue antihypertensive Medikamente ermöglichen bei geeigneten PAH-Patienten eine verlängerte Therapie ohne Transplantation, sodass diese für Patienten mit fehlendem Ansprechen auf die medikamentöse 3-fach-Kombination vorbehalten ist. Ausgehend von den zunehmenden Erfahrungen in der postoperativ verlängerten ECMO konnte ein kardiales Remodeling nach bilateraler Lungentransplantation gezeigt werden.

Schlussfolgerung

Aktuelle Fortschritte in der PAH-Therapie ermöglichen eine bilaterale Lungentransplantation anstelle der kombinierten Herz-Lungen-Transplantation, sodass in dem aktuell herrschenden Organmangel mehr Organe für andere Patienten alloziert werden können. ECMO-Bridging stellt eine lebensrettende Maßnahme bei akuter Dekompensation dar, geht jedoch mit signifikant höheren Komplikationen einher. Eine adäquate Berücksichtigung der Hochrisiko-PAH-Patienten in der Organverteilung könnte die Notwendigkeit eines ECMO-Bridgings minimieren und das Transplantations-Outcome weiter verbessern.

Keywords

transplantation surgery - transplantation - thoracic surgery - long-term survival

Schlüsselwörter

Transplantationschirurgie - Transplantation - Thoraxchirurgie - Langzeitüberleben

Full Text

References

References
1 Chambers DC, Cherikh WS, Harhay MO. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant 2019; 38: 1042-1055
2 Goldfarb SB, Hayes jr D, Levvey BJ. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first Pediatric Lung and Heart-Lung Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018; 37: 1196-1206
3 Christie JD, Van Raemdonck D, Fisher AJ. Lung Transplantation. N Engl J Med 2024; 391: 1822-1836
4 Ringshausen FC, Sauer-Heilborn A, Buttner T. et al. Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012–2021. Eur Respir J 2023; 61: 2201402
5 Sommer W, Warnecke G. Lung transplantation for pediatric pulmonary arterial hypertension-quo vadis?. Cardiovasc Diagn Ther 2021; 11: 1178-1189
6 Melicoff E, Hayes jr D, Benden C. Lung transplantation as an intervention for pediatric pulmonary hypertension. Pediatr Pulmonol 2021; 56: 587-592
7 Avdimiretz N, Benden C. The changing landscape of pediatric lung transplantation. Clin Transplant 2022; 36: e14634
8 Jack T, Carlens J, Diekmann F. et al. Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up. Front Cardiovasc Med 2023; 10: 1193326
9 Ahmed HF, Guzman-Gomez A, Desai M. et al. Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis. Pediatr Cardiol 2024; 45: 385-393
10 Hoeper MM, Benza RL, Corris P. et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J 2019; 53
11 Quezada-Loaiza CA, de Pablo Gafas A, Perez V. et al. Lung Transplantation in Pulmonary Hypertension: A Multidisciplinary Unit’s Management Experience. Transplant Proc 2018; 50: 1496-1503
12 Savale L, Benazzo A, Corris P. et al. Transplantation, bridging, and support technologies in pulmonary hypertension. Eur Respir J 2024; 64: 2401193
13 Kolaitis NA. Lung Transplantation for Pulmonary Arterial Hypertension. Chest 2023; 164: 992-1006
14 Hwalek A, Rosenheck JP, Whitson BA. Lung transplantation for pulmonary hypertension. J Thorac Dis 2021; 13: 6708-6716
15 Moser B, Jaksch P, Taghavi S. et al. Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg 2018; 53: 178-185
16 Glorion M, Mercier O, Mitilian D. et al. Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. Eur J Cardiothorac Surg 2018; 54: 341-347
17 Brouckaert J, Verleden SE, Verbelen T. et al. Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study. Transpl Int 2019; 32: 717-729
18 Tudorache I, Sommer W, Kuhn C. et al. Lung transplantation for severe pulmonary hypertension--awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation 2015; 99: 451-458
19 Salman J, Ius F, Sommer W. et al. Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension. Eur J Cardiothorac Surg 2017; 52: 163-170
20 Kruszona S, Aburahma K, Wand P. et al. Extracorporeal membrane oxygenation as a bridge to transplant in severe pulmonary hypertension. Eur J Cardiothorac Surg 2024; 66
21 Humbert M, Sitbon O, Guignabert C. et al. Treatment of pulmonary arterial hypertension: recent progress and a look to the future. Lancet Respir Med 2023; 11: 804-819
22 Weatherald J, Boucly A, Peters A. et al. The evolving landscape of pulmonary arterial hypertension clinical trials. Lancet 2022; 400: 1884-1898
23 Bisserier M, Pradhan N, Hadri L. Current and emerging therapeutic approaches to pulmonary hypertension. Rev Cardiovasc Med 2020; 21: 163-179
24 Weatherald J, Varughese RA, Liu J. et al. Management of Pulmonary Arterial Hypertension. Semin Respir Crit Care Med 2023; 44: 746-761
25 Humbert M, Kovacs G, Hoeper MM. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618-3731
26 Humbert M, Kovacs G, Hoeper MM. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023; 61: 2200879
27 Weatherald J, Hemnes AR, Maron BA. et al. Phenotypes in pulmonary hypertension. Eur Respir J 2024; 64: 2301633
28 Condliffe R, Durrington C, Hameed A. et al. Clinical-radiological-pathological correlation in pulmonary arterial hypertension. Eur Respir Rev 2023; 32: 230138
29 Kovacs G, Bartolome S, Denton CP. et al. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J 2024; 64: 2401324
30 Kim NH, D’Armini AM, Delcroix M. et al. Chronic thromboembolic pulmonary disease. Eur Respir J 2024; 64: 2401294
31 de Perrot M, Gopalan D, Jenkins D. et al. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension – consensus statement from the ISHLT. J Heart Lung Transplant 2021; 40: 1301-1326
32 Boucly A, Gerges C, Savale L. et al. Pulmonary arterial hypertension. Presse Med 2023; 52: 104168
33 Khangoora VS, King CS, Shlobin OA. Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation. Curr Opin Organ Transplant 2022; 27: 169-176
34 Abu T, Levi A, Hasdai D. et al. Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization. BMC Cardiovasc Disord 2022; 22: 53
35 Chen Y, Liang J, Li Q. et al. Clinical outcome of lung transplantation for chronic thromboembolic pulmonary hypertension. BMC Pulm Med 2024; 24: 410
36 Humbert M, McLaughlin V, Gibbs JSR. et al. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension. Eur Respir J 2023; 61: 2201347
37 Hoeper MM, Badesch DB, Ghofrani HA. et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med 2023; 388: 1478-1490
38 Olsson KM, Richter MJ, Kamp JC. et al. Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation. Eur Respir J 2022; 60: 2103087
39 Vraka A, Diamanti E, Kularatne M. et al. Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives. J Clin Med 2023; 12: 4349
40 Ahmed A, Ahmed S, Radegran G. Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines. Pulm Circ 2023; 13: e12253
41 Ahmed A, Ahmed S, Radegran G. Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age-Where do we stand and what’s next?. Pulm Circ 2023; 13: e12314
42 Ishii S, Hatano M, Minatsuki S. et al. Comprehensive Risk Assessment in Patients With Pulmonary Arterial Hypertension Referred for Lung Transplantation. Circ J 2024; 88: 1610-1617
43 Chin KM, Gaine SP, Gerges C. et al. Treatment algorithm for pulmonary arterial hypertension. Eur Respir J 2024; 64: 2401325
44 Preston IR, Howard LS, Langleben D. et al. Management of pulmonary hypertension in special conditions. Eur Respir J 2024; 64: 2401180
45 Benza RL, Gomberg-Maitland M, Miller DP. et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012; 141: 354-362
46 Benza RL, Miller DP, Gomberg-Maitland M. et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164-172
47 Benza RL, Gomberg-Maitland M, Elliott CG. et al. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. Chest 2019; 156: 323-337
48 Hoeper MM, Pausch C, Olsson KM. et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J 2022; 60: 2102311
49 Hoeper MM, Kramer T, Pan Z. et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017; 50: 1700740
50 Lechartier B, Boucly A, Solinas S. et al. Pulmonary veno-occlusive disease: illustrative cases and literature review. Eur Respir Rev 2024; 33: 230156
51 Vicaire H, Pavec JL, Mercier O. et al. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation. J Heart Lung Transplant 2022; 41: 1285-1293
52 Leard LE, Holm AM, Valapour M. et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021; 40: 1349-1379
53 Cypel M, Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir Med 2020; 8: 944-946
54 Gottlieb J, Greer M, Sommerwerck U. et al. Introduction of the lung allocation score in Germany. Am J Transplant 2014; 14: 1318-1327
55 Toyoda Y, Toyoda Y. Heart-lung transplantation: adult indications and outcomes. J Thorac Dis 2014; 6: 1138-1142
56 Le Pavec J, Hascoet S, Fadel E. Heart-lung transplantation: current indications, prognosis and specific considerations. J Thorac Dis 2018; 10: 5946-5952
57 Chen H, Shiboski SC, Golden JA. et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med 2009; 180: 468-474
58 Kolaitis NA, Chen H, Calabrese DR. et al. The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision. Am J Respir Crit Care Med 2023; 207: 300-311
59 Zhu S, Zhou M, Wei D. et al. Risk Analysis of Perioperative Death in Lung Transplant Patients With Severe Idiopathic Pulmonary Hypertension. Transplant Proc 2019; 51: 875-879
60 Hu X, Ding N, Songchen W. et al. Lung Transplantation for Pulmonary Arterial Hypertension: Optimized Referral and Listing Based on an Evolving Disease Concept. J Cardiovasc Dev Dis 2023; 10: 350
61 Girgis RE, Manandhar-Shrestha NK, Krishnan S. et al. Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension. Pulm Circ 2024; 14: e12371
62 Le Pavec J, Feuillet S, Mercier O. et al. Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France. J Heart Lung Transplant 2021; 40: 652-661
63 Hascoet S, Pontailler M, Le Pavec J. et al. Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program. Am J Transplant 2021; 21: 3388-3400
64 Bartolome S, Hoeper MM, Klepetko W. Advanced pulmonary arterial hypertension: mechanical support and lung transplantation. Eur Respir Rev 2017; 26: 170089
65 Ius F, Tudorache I, Warnecke G. Extracorporeal support, during and after lung transplantation: the history of an idea. J Thorac Dis 2018; 10: 5131-5148
66 Hoeper MM. Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects. Semin Respir Crit Care Med 2023; 44: 771-776
67 Ius F, Sommer W, Tudorache I. et al. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes. Interact Cardiovasc Thorac Surg 2015; 20: 761-767
68 Fuehner T, Kuehn C, Hadem J. et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185: 763-768
69 Iablonskii P, Carlens J, Mueller C. et al. Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience. J Heart Lung Transplant 2022; 41: 226-236
70 Orlitova M, Goos W, Van Slambrouck J. et al. Complications related to extracorporeal life support in lung transplantation: single-center analysis. J Thorac Dis 2023; 15: 6301-6316
71 Fischer S, Simon AR, Welte T. et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 2006; 131: 719-723
72 Strueber M, Hoeper MM, Fischer S. et al. Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant 2009; 9: 853-857
73 Saeed O, Stein LH, Cavarocchi N. et al. Outcomes by cannulation methods for venovenous extracorporeal membrane oxygenation during COVID-19: A multicenter retrospective study. Artif Organs 2022; 46: 1659-1668
74 Capoccia M, Brewer JM, Rackauskas M. et al. Outcome of Veno-Pulmonary Extracorporeal Life Support in Lung Transplantation Using ProtekDuo Cannula: A Systematic Review and Description of Configurations. J Clin Med 2024; 13: 4111
75 Corris PA. Atrial septostomy and transplantation for patients with pulmonary arterial hypertension. Semin Respir Crit Care Med 2009; 30: 493-501
76 Gorbachevsky SV, Shmalts AA, Dadabaev GM. et al. Outcomes of Atrioseptostomy with Stenting in Patients with Pulmonary Arterial Hypertension from a Large Single-Institution Cohort. Diagnostics (Basel) 2020; 10: 725
77 Gazengel P, Hascoët S, Amsallem M. et al. Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension. Eur Respir J 2022; 59: 2102388
78 Capel A, Levy M, Szezepanski I. et al. Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect. ESC Heart Fail 2021; 8: 326-332
79 Grady RM, Canter MW, Wan F. et al. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension. J Am Coll Cardiol 2021; 78: 468-477
80 Symersky P, Jansen SMA, Kamminga SK. et al. Improvement in exercise capacity after a modified Potts shunt in an adult patient with pulmonary arterial hypertension. ERJ Open Res 2021; 7: 00287–2021
81 Haddad RN, Levy M, Szezepanski I. et al. Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension. Front Cardiovasc Med 2022; 9: 1028304
82 Valdeolmillos E, Le Pavec J, Audie M. et al. Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation. J Thorac Cardiovasc Surg 2024; 168: 943-954
83 Nellis JR, Haney JC, Turek JW. Commentary: Repair or replace-Potts shunt versus lung transplantation for refractory pediatric pulmonary hypertension. J Thorac Cardiovasc Surg 2021; 161: 1153-1154
84 Rosenzweig EB, Bacha E. Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?. J Thorac Cardiovasc Surg 2021; 161: 1150-1151
85 Paradela M, Mercier O, Baruteau A. et al. Endovascular closure of Potts shunt before double lung transplantation for idiopathic pulmonary arterial hypertension. J Thorac Cardiovasc Surg 2013; 146: e5-e7
86 Stącel T, Sybila P, Mędrala A. et al. Novel Hybrid Treatment for Pulmonary Arterial Hypertension with or without Eisenmenger Syndrome: Double Lung Transplantation with Simultaneous Endovascular or Classic Surgical Closure of the Patent Ductus Arteriosus (PDA). J Cardiovasc Dev Dis 2022; 9: 457
87 Peer SB, Loor G, Han JW. et al. Surgical right pulmonary artery to left atrial shunt for severe pulmonary hypertension and bridge to lung transplantation. JTCVS Tech 2024; 23: 178-181
88 Kayawake H, Tanaka S, Yamada Y. et al. Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension. Eur J Cardiothorac Surg 2023; 63: ezad024
89 Kayawake H, Date H. Living-donor lobar lung transplantation: a viable option for recipients with pulmonary hypertension. Eur J Cardiothorac Surg 2023; 63: ezad132
90 de Manna ND, Aburahma K, Kruszona S. et al. Single Lung Transplantation in a Highly Selected Patient With End-Stage Chronic Thromboembolic Pulmonary Hypertension. Clin Transplant 2024; 38: e15483
91 Sunagawa G, Kehara H, Mangukia C. et al. Single Lung Transplant Remains a Viable Option for Patients With Severe Secondary Pulmonary Hypertension. Transplantation 2022; 106: 2241-2246
92 Housman B, Laskey D, Dawodu G. et al. Single Lung Transplant for Secondary Pulmonary Hypertension: The Right Option for the Right Patient. J Clin Med 2023; 12: 6789
93 Nasir BS, Mulvihill MS, Barac YD. et al. Single lung transplantation in patients with severe secondary pulmonary hypertension. J Heart Lung Transplant 2019; 38: 939-948
94 Toyoda Y, Thacker J, Santos R. et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg 2008; 86: 1116-1122
95 Fadel E, Mercier O, Mussot S. et al. Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. Eur J Cardiothorac Surg 2010; 38: 277-284
96 Hill C, Maxwell B, Boulate D. et al. Heart-lung vs. double-lung transplantation for idiopathic pulmonary arterial hypertension. Clin Transplant 2015; 29: 1067-1075
97 Lopez-Meseguer M, Quezada CA, Ramon MA. et al. Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One 2017; 12: e0187811
98 Whitson BA, Prekker ME, Herrington CS. et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 2007; 26: 1004-1011
99 Hansmann G, Diekmann F, Chouvarine P. et al. Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH. J Heart Lung Transplant 2022; 41: 187-198
100 Otto M, McGiffin D, Whitford H. et al. Survival and left ventricular dysfunction post lung transplantation for pulmonary arterial hypertension. J Crit Care 2022; 72: 154120
101 Aggarwal R, Potel KN, Jackson S. et al. Impact of lung transplantation on diastolic dysfunction in recipients with pretransplant pulmonary hypertension. J Thorac Cardiovasc Surg 2024; 167: 1643-1653.e2
102 Bando K, Armitage JM, Paradis IL. et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994; 108: 1056-1065
103 Poveda D, Ruiz E, Fernandez AM. et al. Lung Transplantation in a Young Patient With Pulmonary Artery Hypertension After Arterial Switch Operation: A Case Report. Transplant Proc 2022; 54: 65-67
104 Schwarz S, Benazzo A, Prosch H. et al. Lung transplantation for pulmonary hypertension with giant pulmonary artery aneurysm. J Thorac Cardiovasc Surg 2020; 159: 2543-2550
105 Pelenghi S, Primiceri C, Belliato M. et al. Is it time for a paradigm shift: Should double-lung transplant be considered the treatment of choice for idiopathic pulmonary arterial hypertension and giant pulmonary aneurysm?. J Card Surg 2021; 36: 2996-2999
106 Doi A, Gajera J, Niewodowski D. et al. Surgical management of giant pulmonary artery aneurysms in patients with severe pulmonary arterial hypertension. J Card Surg 2022; 37: 1019-1025
107 Worku B, Mack C, Gambardella I. Bilateral lung transplant for pulmonary hypertension with pulmonary artery aneurysm. J Card Surg 2022; 37: 1026-1027
108 Poveda D, Fadel E, Lorenzi W. et al. A bilateral lung transplant and giant pulmonary artery aneurysm reconstruction with an aortic graft in a woman with pulmonary hypertension. Eur J Cardiothorac Surg 2022; 62: ezac538
109 Watanabe T, Matsuo S, Watanabe Y. et al. Bilateral lung transplant with pulmonary artery reconstruction using donor aorta for pulmonary hypertension with a giant pulmonary arterial aneurysm. Eur J Cardiothorac Surg 2023; 63: ezad234
110 Sertic F, Han J, Diagne D. et al. Not All Septal Defects Are Equal: Outcomes of Bilateral Lung Transplant With Cardiac Defect Repair vs Combined Heart-Lung Transplant in Patients With Eisenmenger Syndrome in the United States. Chest 2020; 158: 2097-2106
111 Kayawake H, Aoyama A, Kinoshita H. et al. Diameter of the dilated main pulmonary artery in patients with pulmonary hypertension decreases after lung transplantation. Surg Today 2020; 50: 275-283
112 Ius F, Kuehn C, Tudorache I. et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg 2012; 144: 1510-1516
113 Dell’Amore A, Campisi A, Congiu S. et al. Extracorporeal life support during and after bilateral sequential lung transplantation in patients with pulmonary artery hypertension. Artif Organs 2020; 44: 628-637
114 Stącel T, Kegler K, Mędrala A. et al. Lung Transplantation in Patients With Pulmonary Hypertension With Extracorporeal Membrane Oxygenation (ECMO) Support: 5-Year Experience. Transplant Proc 2024; 56: 898-903
115 Matias MV, Cruz Z, Figueiredo C. et al. Lung Transplantation in Pulmonary Arterial Hypertension: The Portuguese Experience. Transplant Proc 2024; 56: 1115-1120
116 Sabashnikov A, Mohite PN, Zeriouh M. et al. The role of extracorporeal life support in the management with severe idiopathic pulmonary artery hypertension undergoing lung transplantation: are those patients referred too late?. J Thorac Dis 2019; 11: S929-S937
117 Ius F, Aburahma K, Boethig D. et al. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation. J Heart Lung Transplant 2020; 39: 915-925
118 Goldstein BS, Sweet SC, Mao J. et al. Lung transplantation in children with idiopathic pulmonary arterial hypertension: an 18-year experience. J Heart Lung Transplant 2011; 30: 1148-1152
119 Hubbard R, Miller R, Tumin D. et al. Transplant outcomes for idiopathic pulmonary hypertension in children. J Heart Lung Transplant 2019; 38: 580-581
120 Pereszlenyi A, Lang G, Steltzer H. et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg 2002; 21: 858-863
121 Aigner C, Wisser W, Taghavi S. et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007; 31: 468-473
122 Porteous MK, Ky B, Kirkpatrick JN. et al. Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med 2016; 193: 1392-1400